Document:

Exhibit 10.91

 

“THE SECURITIES
EVIDENCED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY
STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT (i) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO,
(ii) AN OPINION OF COUNSEL OR OTHER EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATIONS ARE NOT REQUIRED,
(iii) RECEIPT OF NO-ACTION LETTERS FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES, OR (iv) OTHERWISE COMPLYING WITH THE
PROVISIONS OF SECTION 9 OF THE WARRANT UNDER WHICH THESE SECURITIES WERE ISSUED, DIRECTLY OR INDIRECTLY.”

 

	No. _______	October 5, 2015 (“Issuance Date”)

 

TWINLAB CONSOLIDATED HOLDINGS, INC.

 

COMMON STOCK PURCHASE WARRANT 

 

THIS CERTIFIES THAT,
for value received, TWINLAB CONSOLIDATED HOLDINGS, INC., a Nevada corporation
(the “Company”), grants to GOLISANO
HOLDINGS LLC, a New York limited liability company (“GHL” and together with any successors and assigns
“Holder”) the right to purchase shares of the Company’s common stock, par value $0.001
per share (the “Common Stock”), on the terms and conditions
set forth herein. This Warrant is being issued pursuant to that certain Securities Purchase Agreement dated the date hereof (as
amended from time to time the “Purchase Agreement”) by
between the Company and GHL. 

 

This Warrant is intended
to maintain, following each future issuance of shares of Common Stock pursuant to the conversion, exercise or exchange of any Qualified
Derivative Securities (as defined below), the Holder’s proportional ownership of the Company’s issued outstanding Common
Stock (“Common Stock Proportional Ownership”) so that it is the same thereafter as it was on the Issuance
Date. On each date, the Holder’s Common Stock Proportional Ownership shall equal the ratio, as of such date, of (i) the shares
of Common Stock acquired by GHL pursuant to the Purchase Agreement on the Closing Date (as defined therein) (which is 88,711,241
shares and subject to proportional and appropriate adjustment for all stock splits,
dividends, combinations, recapitalizations and the like), to (ii) all shares of Common
Stock which are issued and outstanding on such date. As of the Issuance Date, the Holder’s Common Stock Proportional Ownership
is 0.30. After the Issuance Date, if the number of shares of Common Stock of the Company which are issued and outstanding increases
due to the issuance of shares of Common Stock pursuant to the conversion, exercise or exchange of Qualified Derivative Securities,
then Holder shall be entitled to purchase under this Warrant a sufficient number of additional shares of Common Stock so that the
ratio of the figures set forth in (i) to (ii) above as of such date returns to 0.30. Accordingly, this Warrant is exercisable upon
each issuance of shares of Common Stock pursuant to a conversion, exercise or exchange of any Qualified Derivative Securities,
or as otherwise specifically provided herein and on the terms and conditions set forth below.

 

     

     

    

 

1.          Issue.
Upon exercise of this Warrant in accordance with Section 6 below, the Company shall, subject to adjustment as provided
in Section 7 below, issue to the Holder the number of fully paid and non-assessable shares of Common Stock specified in Section
2 below.

 

2.          Number
of Shares of Common Stock. From and after the Issuance Date, the Holder shall be entitled to receive upon each
exercise of this Warrant the number of shares of Common Stock computed according to the following formula:

 

A = (B x C) / (1-C)

 

Where,

 

A = the number
of shares of Common Stock that may be purchased by the Holder upon each exercise of this Warrant,

 

B = the number
of shares of Common Stock issued by the Company from time to time on and after the Issuance Date pursuant to a conversion, exercise
or exchange of any Qualified Derivative Securities and with respect to which this Warrant has not previously been exercised, and

 

C = the Holder’s
Issuance Date Common Stock Proportional Ownership which is 0.30.

 

Notwithstanding any
provision contained in this Warrant to the contrary, the Company shall not issue fractional Warrant Shares (as defined below) upon
exercise of this Warrant. If the Holder is entitled to purchase Warrant Shares hereunder and based on the foregoing formula the
Holder would be entitled to purchase a fractional Warrant Share, then such purchase right shall be rounded up to the nearest whole
number.

 

For example, if after
the Issuance Date the Company issues 17,342,105 shares of Common Stock pursuant to the conversion, exercise or exchange of Qualified
Derivative Securities, then the Holder shall be entitled to purchase 7,432,331 shares of Common Stock. If thereafter the Company
issues another 403,509 shares pursuant to a conversion, exercise or exchange of any Qualified Derivative Securities, then the Holder
shall be entitled to purchase another 172,933 shares of Common Stock. The table attached hereto as Exhibit D is hereby
incorporated by reference.

 

3.           Definitions.
As used herein, the following terms apply:

 

(a)          “Derivative
Securities” means any securities of the Company or the Subsidiaries which would
entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right,
option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles
the holder thereof to receive, Common Stock.

 

    2 

     

    

 

(b)          “Qualified
Derivative Securities” means all Derivative Securities granted prior to the Issuance Date or which are issued
in exchange for or in replacement of such Derivative Securities. The Company represents and warrants to the Holder that the Qualified
Derivative Securities that are outstanding on the Issuance Date are set forth on Exhibit A hereto.

 

(c)          “Warrant
Shares” means the shares of Common Stock (or other securities or property) that may be purchased under this
Warrant.

 

4.            Exercise
Price. Subject to adjustment as provided in Section 7 below, the exercise price for the purchase of each Warrant
Share hereunder is $.001 per share or such lesser amount as equals the par value of the Common Stock upon exercise of this Warrant
(the “Exercise Price”). The aggregate Exercise Price due
upon each exercise of this Warrant shall be the Exercise Price multiplied by the number of Warrant Shares being purchased upon
such exercise.

 

5.            Exercise
Period. This Warrant may be exercised at any time and from time to time in accordance with Section 6 below from
the Issuance Date, up to and including the date which is sixty (60) days after the later to occur of the termination, expiration,
conversion, exercise or exchange of all the Qualified Derivative Securities and the Company’s delivery of written notice
thereof to the Holder in accordance with Section 12 below, provided as of such date and the Company has honored all of its obligations
hereunder (the “Exercise Period”). For avoidance of doubt,
this Warrant may be exercised at any time on and after any Qualified Derivative Securities are exercised, converted or exchanged
for shares of Common Stock. All rights to purchase Warrant Shares shall expire and lapse as of 12:00 midnight on the last day of
the Exercise Period provided the Company has honored all of its obligations hereunder as of such time. Upon expiration of the Exercise
Period, the Holder shall surrender to the Company the original of this Warrant.

 

6.            Exercise
of Warrant; Issuance of Certificates.

 

(a)          This
Warrant may be exercised, in whole or in part, upon each issuance of shares of Common Stock pursuant to a conversion, exercise
or exchange of any Qualified Derivative Securities.

 

(b)          The
Holder may exercise this Warrant by the Holder’s actual delivery of (i) the aggregate Exercise Price due with respect to
the Warrant Shares being purchased in cash or by check, and (ii) a duly executed Warrant Exercise Form, a copy of which is attached
to this Warrant as Exhibit B, properly executed by the Holder.
Notwithstanding the foregoing, this Warrant shall be deemed exercised upon the consummation of any Major Transaction (as defined
below) if any Qualified Derivative Securities are exercised, converted or exchanged in connection with a Major Transaction (as
defined below),

 

    3 

     

    

 

(c)          Any
Warrant Shares purchased hereunder shall be deemed to be issued to the Holder as of the date of the exercise, conversion or exchange
of the Qualified Derivative Securities or the consummation of the Major Transaction, in each case that gave rise to the Holder’s
right to purchase such Warrant Shares or receive payment pursuant hereto. The payment and any required Warrant Exercise Form must
be delivered to the Company’s offices either in person or as set forth in Section 11.

 

(d)          Certificates
for the Warrant Shares purchased hereunder shall be delivered to the Holder within a reasonable time, not exceeding five (5) business
days, after this Warrant is deemed exercised. The certificates so delivered shall be in such denominations as may be requested
by the Holder and shall be registered in the name of the Holder or such other name as shall be designated by the Holder.

 

7.            Certain
Transactions.

 

(a)          Major
Transactions. If there shall occur any recapitalization (including a combination or subdivision of outstanding shares
of Common Stock), capital reorganization or reclassification of the issued and outstanding shares of Common Stock, or any consolidation
or merger of the Company or any subsidiary of the Company with or into another corporation, or a transfer of all or substantially
all of the assets of the Company and/or any subsidiary resulting in payment to the holders of the issuance and outstanding shares
of Common Stock, or the payment of a liquidating distribution to the holders of issued and outstanding shares of Common Stock (each
a “Major Transaction”), then the following provisions shall
apply:

 

(i)          As
part of any Major Transaction, lawful provision shall be made so that the Holder shall have the right to receive, upon the exercise
of the portion of this Warrant then exercisable, the kind and amount of shares of stock or other securities or property (including
cash) that the Holder would have been entitled to receive if, immediately before or concurrently with the consummation of any such
Major Transaction, the Holder had held the number of shares of Common Stock which could then have been purchased upon the exercise
of this Warrant. Upon receipt of any such shares of stock or other securities or property (including cash) that portion of the
Warrant with respect to which the Holder received such shares of stock or other securities or property (including cash) shall be
deemed exercised.

 

(ii)         If,
as part of a Major Transaction, the surviving entity in any such Major Transaction or purchaser of assets (each a “Surviving
Entity”) plans to assume any Qualified Derivative Securities after such Major Transaction is consummated (the
“Assumed Warrants/Options”), then lawful provision
shall be made so that (A) the portion of the purchase rights hereunder that correspond to the Assumed Warrants/Options will also
be assumed and honored by the Surviving Entity and (B) the Holder will be entitled with respect thereto to purchase the same types
of shares and securities for which the Assumed Warrants/Options are exercisable on the same relative terms and Exercise Price as
provided herein.

 

(iii)        If
a Major Transaction is not a merger, consolidation or sale of substantially all of the assets of the Company and/or one or more
of its subsidiaries, then this Warrant shall continue to remain in effect as provided herein after consummation of such Major Transaction
to the extent any purchase rights hereunder correspond to any portion of any Qualified Derivative Securities which also so remain
in effect.

 

    4 

     

    

 

(iv)        If
the Company or any Surviving Entity, or their respective agents or representatives, makes a payment to any holder of Qualified
Derivative Securities (“Terminated Qualified Derivative Securities”)
at any time in consideration for the termination of, agreement not to exercise, or any similar undertaking with respect to, such
Qualified Derivative Securities, then legal provision shall be made so that payment is also made to Holder at the same time with
respect to the portion of the purchase rights under this Warrant which correspond to the Terminated Qualified Derivative Securities.
Such payment to Holder will be calculated in accordance with the formula set forth in Section 2, except variable A will equal the
payment to Holder under this Section 7(a)(iv) and variable B will equal the aggregate payment to holders of Terminated Qualified
Derivative Securities described in the preceding sentence. Upon receipt of any such payment that portion of the Warrant with respect
to which the Holder received such payment shall be deemed exercised.

 

(v)         With
respect to the foregoing, appropriate adjustment shall be made in the application of the provisions set forth herein with respect
to the rights and interests thereafter of the Holder such that the provisions set forth in this Section 7 (including provisions
with respect to adjustment of the Exercise Price) shall thereafter be applicable, as nearly as is reasonably practicable, in relation
to any shares of stock or other securities or property thereafter deliverable upon the exercise of the Warrants. Without limiting
the foregoing, the Company acknowledges and agrees that more than one of the foregoing subsections of this Section 7 may apply
to this Warrant in a Major Transaction if the Qualified Derivative Securities do not have uniform terms and complete exercise of
purchase rights in connection therewith. For purposes hereof, purchase rights under this Warrant “correspond” to Qualified
Derivative Securities based on the number of shares which are or may be purchasable with respect thereto in accordance with the
formula set forth in Section 2 above.

 

(b)          Certain
Other Events. If any event occurs of the type contemplated by the provisions of this Section 7 but not expressly
provided for by such provisions which are not otherwise provided for herein, then the Company shall make appropriate adjustment
to the terms hereof so as to protect the rights of the Holder so that it receives an economically equivalent value as it would
otherwise have been entitled to hereunder; provided, however, that no such adjustment will increase the Exercise Price as otherwise
determined pursuant to this Section 7.

 

(c)          Certificate
as to Adjustments. Upon the occurrence of each adjustment or readjustment pursuant to this Section 7, the Company
at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and furnish to the Holder
a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment
is based and shall file a copy of such certificate with its corporate records.

 

    5 

     

    

 

8.            Certain
Company Undertakings.

 

(a)          No
Impairment. The Company will not, by amendment of its Articles of Incorporation or By-Laws or through any reorganization,
transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action involving the
Company and/or one or more of its subsidiaries, avoid or seek to avoid the observance or performance of any of the terms to be
observed or performed hereunder by the Company, but will at all times in good faith assist in the carrying out of all the provisions
of this Warrant and in the taking of all such actions as may be necessary or appropriate in order to protect the exercise privilege
of the Holder against dilution or other impairment, consistent with the tenor and purpose of this Warrant. Without limiting the
generality of the foregoing, the Company (i) will not increase the par value of any shares of Common Stock receivable upon the
exercise of this Warrant above the Exercise Price then in effect, and (ii) will take all such actions as may be necessary or appropriate
in order that the Company may validly and legally issue fully paid and non-assessable shares of Common Stock upon the exercise
of this Warrant.

 

(b)          Notice.

 

(i)          Promptly
following receipt of notice of the conversion, exercise or exchange of any Qualified Derivative Securities, the Company shall deliver
to the Holder a written certificate signed by an officer of the Company (“Warrant Purchase Rights Notice Certificate”)
which sets forth therein the number of such shares of Common Stock being issued pursuant thereto, the date on which issuance will
occur, the number of Warrant Shares which the Holder of this Warrant is entitled purchase upon exercise hereof, the aggregate Exercise
Price due therefor and all supporting facts and calculations. The Company shall keep a copy of each Warrant Purchase Rights Notice
Certificate with the Company’ corporate records. The Company shall promptly provide the Holder with a copy of each Warrant
Purchase Rights Notice Certificate upon any request therefor by the Holder.

 

(ii)         In
the event that the Company proposes to engage in a Major Transaction, then the Company shall provide written notice (a “Major
Transaction Notice”) thereto to the Holder which shall state the date on which the Major Transaction is scheduled
to be consummated and terms of such Major Transaction, including the effect of the conversion, exercise or exchange of any Qualified
Derivative Securities and the adjustment to this Warrant as a result thereof as provided in Section 7 herein (e.g., the number
of Warrant Shares or other securities or property (including cash) that the Holder is entitled to receive and the aggregate Exercise
Price due from the Holder as a result thereof). Within 10 days following the consummation of the Major Transaction, the Company
shall deliver to the Holder a written certificate signed by an officer of the Company or the Surviving Entity if applicable
(“Major Transaction Consummation Notice Certificate”) thereto to the Holder of the consummation of the
Major Transaction and any variations of the terms disclosed in the Major Transaction Notice as well as the other information required
by Section 7(a) above.

 

9.            Compliance
with Act; Disposition of Warrant or Shares of Common Stock.

 

(a)          The
Holder, by acceptance hereof, agrees that this Warrant, and the Warrant Shares to be issued upon exercise hereof are being acquired
for investment and that the Holder will not offer, sell or otherwise dispose of this Warrant, or any Warrant Shares to be issued
upon exercise hereof except under circumstances which will not result in a violation of the Securities Act or any applicable state
securities laws. Upon exercise of this Warrant, unless the Warrant Shares being acquired are registered under the Securities Act
and any applicable state securities laws or an exemption from such registration is available, the Holder shall confirm in writing
that the Warrant Shares so purchased are being acquired for investment and not with a view toward distribution or resale in violation
of the Act and shall confirm such other matters related thereto as may be reasonably requested by the Company. This Warrant and
all Warrant Shares issued upon exercise of this Warrant (unless registered under the Act and any applicable state securities laws)
shall be stamped or imprinted with a legend in substantially in the form required by the Purchase Agreement.Said legend shall be
removed by the Company, upon the written request of the Holder, at such time as the restrictions on the transfer of the applicable
security shall have terminated.

 

    6 

     

    

 

(b)          With
respect to any offer, sale or other disposition of this Warrant or any Warrant Shares acquired pursuant to the exercise of this
Warrant prior to registration of such Warrant or Warrant Shares, the Holder agrees to give written notice to the Company prior
thereto, describing briefly the manner thereof, together with a written opinion of counsel, if requested by the Company, or other
evidence, if reasonably satisfactory to the Company, to the effect that such offer, sale or other disposition may be effected without
registration or qualification (under the Act as then in effect or any federal or state securities law then in effect) of this Warrant
or such Warrant Shares of Common Stock and indicating whether or not under the Act certificates for this Warrant or such Warrant
Shares to be sold or otherwise disposed of require any restrictive legend as to applicable restrictions on transferability in order
to ensure compliance with such law. Upon receiving such written notice and reasonably satisfactory opinion or other evidence, the
Company shall be deemed to have consented to such transfer, which shall not be unreasonably withheld, delayed or conditioned (except
with respect to any transfer to any affiliate of the Holder as described more fully in Section 9(c) below, in which case no
consent shall be required) (any such transfer as to which no consent is required or consent has been deemed granted, a “Permitted
Transfer”). If a determination has been made pursuant to this Section 9(b) that the opinion of counsel or other
evidence is not reasonably satisfactory to the Company, the Company shall so notify the Holder promptly with details thereof after
such determination has been made. Notwithstanding the foregoing, , if applicable, this Warrant or such Warrant Shares may, as to
such federal laws, be offered, sold or otherwise disposed of in accordance with Rule 144 or 144A under the Act, provided that the
Company shall have been furnished with such information as the Company may reasonably request to provide a reasonable assurance
that the provisions of Rule 144 or 144A have been satisfied. Each certificate representing this Warrant or the shares of Common
Stock thus transferred (except a transfer pursuant to Rule 144 or 144A) shall bear a legend as to the applicable restrictions on
transferability in order to ensure compliance with such laws, unless in the aforesaid opinion of counsel for the Holder, such legend
is not required in order to ensure compliance with such laws. The Company may issue stop transfer instructions to its transfer
agent in connection with such restrictions.

 

(c)          Neither
any restrictions of any legend described in this Warrant nor the requirements of Section 9(b) above shall apply to any transfer
of, or grant of a security interest in, this Warrant (or the Warrant Shares) or any part hereof (i) to a partner of the Holder
if the Holder is a partnership or to a member of or other holder of an interest in the Holder if the Holder is a limited liability
company, (ii) to a partnership of which the Holder is a partner or to a limited liability company of which the Holder is a
member or other holder of an interest, or (iii) to any affiliate of the Holder if the Holder is a corporation; provided, however,
in any such transfer, if applicable, the transferee shall on the Company’s request agree in writing to be bound by the terms
of this Warrant as if an original holder hereof.

 

    7 

     

    

 

10.          Registration
Rights. The Warrant Shares are “Registerable Shares” under the Registration Rights Agreement dated
as of October [●], 2015 between the Company and GHL, as amended and/or
restated from time to time (the “Registration Rights Agreement”).

 

11.          Reservation
of Underlying Shares. 

 

(a)          The Company covenants at all times to reserve and keep available out of its authorized shares of Common Stock,
free from preemptive rights, solely for the purpose of issue upon exercise of the Warrant as herein provided, the maximum number
of shares of Common Stock as shall then be issuable upon the exercise of this Warrant. As of the date hereof, the Company has reserved
12,697,977 shares of Common Stock for issuance under this Warrant.

 

(b)          The
Company covenants that all shares of Common Stock issued upon exercise of the Warrant which shall be so issuable shall, when issued,
be duly and validly issued and fully paid and non-assessable, free from all taxes, liens and charges with respect to the purchase
and the issuance of the shares, and shall not have any legend or restrictions on resale, except as required by the Purchase Agreement
or hereby.

 

12.         Notices.
All notices to be given or otherwise made to any party, to this Warrant shall be deemed to be sufficient if contained
in a written instrument, delivered by hand in person, or by express overnight courier service, or by registered or certified mail,
return receipt requested, postage prepaid, addressed to such party at the following addresses or at such other address as may hereafter
be designated in writing by the addressee to the addressor listing all parties.

 

		(a)	If to the Company:

 

TWINLAB CONSOLIDATED HOLDINGS, INC.

632 Broadway, Suite 201

New York, NY 10012

Attn: Richard H. Neuwirth, Chief Legal Officer

Email: RNeuwirth@twinlab.com

 

with a copy to (which copy shall not constitute notice):

 

Wilk Auslander LLP

1515 Broadway, 43rd Floor

New York, NY 10036

Attn: Joel I. Frank, Esq.

 

    8 

     

    

 

		(b)	If to GHL:

 

Golisano Holdings LLC

c/o Fishers Asset Management

1 Fishers Road

Pittsford, NY 14534

Facsimile: (585) 340-1202

 

with
a copy to (which shall not constitute notice):

 

Woods Oviatt
Gilman LLP

700 Crossroads
Building

2 State Street

Rochester, New
York 14614

Attn: Gordon
E. Forth, Esq.

 

All
such notices shall, when delivered by over-night courier or mailed, be effective when received or when attempted delivery is refused.

 

13.         Compliance
with Governmental Requirements. The Company covenants that if any shares of Common
Stock required to be reserved for purposes of exercise of this Warrant require registration with or approval of any governmental
authority under any Federal or state law, or any national securities exchange, before such shares may be issued upon exercise,
the Company will use its best efforts to cause such shares to be duly registered or approved, as the case may be, provided, however,
that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or file a general
consent to service of process in any such state or jurisdiction.

 

14.         Payment
Of Tax Upon Issue or Transfer. The issuance of certificates for Warrant Shares upon
exercise of this Warrant shall be made without charge to the Holder for any documentary stamp or similar taxes that may be payable
in respect of the issue or delivery of such certificate, provided that the Company shall not be required to pay any tax that may
be payable in respect of any transfer involved in the issuance and delivery of any such certificate upon exercise in a name other
than that of the Holder and the Company shall not be required to issue or deliver such certificates unless or until the person
or persons requesting the issuance thereof shall have paid to the Company the amount of such tax or shall have established to the
satisfaction of the Company that such tax has been paid.

 

15.         Effect
Of Headings: References. The section headings herein are for convenience only and shall
not affect the construction hereof. References herein to Sections are to Sections of this Warrant, unless otherwise expressly provided.

 

16.         No
Rights As Stockholder. This Warrant shall not entitle the Holder to any rights as a
stockholder of the Company with respect to the Warrant Shares, including, without limitation, the right to vote, to receive dividends
and other distributions, or to receive notice of, or to attend, meetings of stockholders or any other proceedings of the Company
solely based on the Warrant Shares, unless and to the extent exercised for Warrant Shares in accordance with the terms hereof.

 

    9 

     

    

 

17.         Successors
and Assigns. This Warrant shall be binding upon and inure to the benefit of the Holder
and its successors and assigns, and shall be binding upon any entity succeeding to the Company by merger or acquisition of all
or substantially all the assets of the Company. This Warrant may be only assigned in whole by the Holder. Upon the execution and
delivery to the Company of a Warrant Assignment Form substantially in the form of Exhibit C
attached hereto together with this Warrant, the Company shall issue to the assignee a warrant as appropriate in accordance with
such assignment.

 

18.         Entire
Agreement: Amendments. The Purchase Agreement, the Warrant and the Exhibits attached
hereto and the Registration Rights Agreement contain the entire agreement between the parties with respect to the subject matter
hereof and supersede all prior and contemporaneous arrangements or undertakings with respect thereto. This Warrant may only be
amended and the observance of any terms of this Warrant may only be waived by a written instrument executed by both the Company
and the Holder.

 

19.         Governing
Law. 

 

(a)          This
Warrant shall be governed by and construed and enforced in accordance with the internal laws of the State of New York without regard
to the principles of conflicts of law thereof, except to the extent that the laws of the State of Nevada shall apply to the issuance
of shares of Common Stock by the Company. 

 

(b)          Each
party hereby irrevocably submits to the nonexclusive jurisdiction of the state and federal courts sitting in Monroe County, New
York, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper. Each party hereby irrevocably
waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy
thereof to such party at the address for such notices to it under this Warrant and agrees that such service shall constitute good
and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to
serve process in any manner permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST,
A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION
CONTEMPLATED HEREBY.

 

[SIGNATURE
PAGE FOLLOWS]

 

    10 

     

    

 

IN
WITNESS WHEREOF, the Company and the Holder have caused this Warrant to be executed as of the date first set forth above.

 

	 	TWINLAB CONSOLIDATED HOLDINGS, INC.
	 	 	 
	 	By:	/s/ Thomas A. Tolworthy
	 	Name: 	Thomas A. Tolworthy
	 	Title:	President and Chief Executive Officer

 

Accepted:

 

Golisano
Holdings LLC

 

	By:	/s/ B. Thomas Golisano
	 	B. Thomas Golisano, Member

 

     

     

    

 

EXHIBIT
A

 

QUALIFIED
DERIVATIVE SECURITIES EXISTING AS OF THE ISSUANCE DATE

 

See
attached.

 

     

     

    

 

EXHIBIT
B

 

WARRANT
EXERCISE FORM

 

		To:	TWINLAB CONSOLIDATED HOLDINGS, INC.

 

The
undersigned hereby: (1) irrevocably subscribes for and offers to purchase ____ shares of Common Stock of Twinlab Consolidated Holdings,
Inc., pursuant to that certain Common Stock Purchase Warrant dated October 2,
2015 issued to Golisano Holdings LLC; (2) encloses a payment of $_______________ for these shares at a price of $.001 per share
(as adjusted pursuant to the provisions of the Warrant); and (3) requests that a certificate for the shares be issued in the name
of the undersigned and delivered to the undersigned at the address specified below.

 

	 	Golisano Holdings LLC
	 	 
	 	Signature of Holder 
	 	B. Thomas Golisano
	 	 
	 	Address:
	 	 
	 	 
	 	 

 

     

     

    

 

EXHIBIT
C

 

WARRANT
ASSIGNMENT FORM

 

To:
TWINLAB CONSOLIDATED HOLDINGS, INC.

 

Reference
is made to the enclosed Common Stock Purchase Warrant dated October 2,
2015, issued by Twinlab Consolidated Holdings, Inc. to Golisano Holdings LLC (the “Assigned
Warrant”).  All capitalized terms used herein shall have the meanings
given thereto in the Assigned Warrant.

 

For
consideration received, the undersigned does hereby assign and transfer to the person whose name and address appears below (the
“Assignee”) all of the undersigned’s right to purchase shares of
the Common Stock of Twinlab Consolidated Holdings, Inc. (the “Corporation”)
pursuant to the Assigned Warrant. The undersigned
hereby appoints ______________________________ as my attorney, with full power of substitution, to affect the transfer of the Assigned
Warrant of the books of the Corporation. The undersigned hereby requests that a new warrant in the form of the Assigned Warrant
be issued to the Assignee with such changes thereto as may be necessary to reflect this Assignment.

 

	Name and Address of Assignee:	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 

 

	 	Assignor:
	 	 
	 	 

 

     

     

    

 

Exhibit
D

 

Table

 

See attached.Exhibit 10.92

 

REGISTRATION RIGHTS AGREEMENT

 

This Registration Rights Agreement (this
“Agreement”), is made and entered into as of October 5th, 2015, by and between Twinlab Consolidated Holdings,
Inc., a Nevada corporation (the “Company”), and Golisano Holdings LLC, a New York limited liability company
(the “Investor”).

 

A.           In
connection with the Securities Purchase Agreement by and between the parties hereto, dated as of October ___, 2015 (the “SPA” ),
the Company has agreed, upon the terms and subject to the conditions of the SPA, to issue and sell to the Investor (i) 88,711,241
shares (the “Purchased Shares”) of the Company’s common stock, $0.001 par value (“Common Stock”),
and (ii) the Warrant (as defined in the SPA) which will be exercisable to purchase Warrant Shares (as defined in the SPA) in accordance
with the terms of the Warrant.

 

B.           To
induce the Investor to consummate the transactions contemplated by the SPA, the Company has agreed to provide certain registration
rights under the Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute
(collectively, the “Securities Act” ), and applicable state securities laws.

 

NOW, THEREFORE, in consideration of the
foregoing and the mutual and dependent covenants hereinafter set forth, the parties agree as follows:

 

1.           Defined
Terms. Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the SPA.
As used in this Agreement, the following terms shall have the following meanings:

 

“Business
Day” means any day other than Saturday, Sunday or any other day on which commercial banks in New York, New York are authorized
or required by law to remain closed.

 

“Affiliate” of
a Person means any other Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or
is under common control with, such Person. The term “control” (including the terms “controlled by” and
“under common control with”) means the possession, directly or indirectly, of the power to direct or cause the direction
of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.

 

“Agreement” has
the meaning set forth in the preamble.

 

“Board” means
the board of directors of the Company (and any successor governing body of the Company or any successor of the Company).

 

“Closing Date”
has the meaning set forth in the SPA. 

 

     

     

    

 

“Commission” means
the Securities and Exchange Commission or any other federal agency administering the Securities Act and the Exchange Act at the
time.

 

“Common Shares”
means any shares of Common Stock.

 

“Common Stock”
has the meaning set forth in the Recitals and also includes any other common equity securities issued by the Company, and any other
shares of stock issued or issuable with respect thereto (whether by way of a stock dividend or stock split or in exchange for or
upon conversion of such shares or otherwise in connection with a combination of shares, distribution, recapitalization, merger,
consolidation or other corporate reorganization).

 

“Company” has
the meaning set forth in the preamble and includes the Company's successors by merger, acquisition, reorganization or otherwise.

 

“Demand Registration” has
the meaning set forth in Section 2(a).

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, or any successor federal statute, and the rules and
regulations thereunder, which shall be in effect from time to time.

 

“Governmental
Authority” means any federal, state, local or foreign government or political subdivision thereof, or any agency
or instrumentality of such government or political subdivision, or any self-regulated organization or other non-governmental regulatory
authority or quasi-governmental authority (to the extent that the rules, regulations or orders of such organization or authority
have the force of law), or any arbitrator, court or tribunal of competent jurisdiction.

 

“Investor” has
the meaning set forth in the preamble.

 

“Person” means
an individual, corporation, partnership, joint venture, limited liability company, Governmental Authority, unincorporated organization,
trust, association or other entity.

 

“Prospectus” means
the prospectus or prospectuses included in any Registration Statement, as amended or supplemented by any prospectus supplement
with respect to the terms of the offering of any portion of the Registrable Securities covered by such Registration Statement and
by all other amendments and supplements to the prospectus, including post-effective amendments and all material incorporated by
reference in such prospectus or prospectuses.

 

    2 

     

    

 

“Registrable
Securities” means (a) any Common Shares beneficially owned by the Investor, including, but not limited to the Purchased
Shares and the Warrant Shares, and (b) any capital stock of the Company issued or issuable with respect to the Common Shares beneficially
owned by the Investor as a result of any stock split, stock dividend, recapitalization, exchange or similar event or otherwise
or into which any Common Shares beneficially owned by the Investor are converted or exchanged and shares of capital stock of a
Successor Entity (as defined in the Warrant) into which Common Shares owned by the Investor are converted or exchanged, in each
case, without regard to any limitations on exercise of the Warrant (it being understood that for purposes of this Agreement, a
Person shall be deemed to be a holder of Registrable Securities whenever such Person has the right to then acquire or obtain from
the Company any Registrable Securities, whether or not such acquisition has actually been effected). As to any particular Registrable
Securities, such securities shall cease to be Registrable Securities when (i) a Registration Statement covering such securities
has been declared effective by the Commission and such securities have been disposed of pursuant to such effective Registration
Statement, (ii) such securities are sold under circumstances in which all of the applicable conditions of Rule 144 (or any similar
provisions then in force) under the Securities Act are met, (iii) such securities are otherwise transferred and such securities
may be resold without subsequent registration under the Securities Act, or (iv) such securities shall have ceased to be outstanding.

 

“Registration
Statement” means any registration statement of the Company which covers any of the Registrable Securities pursuant
to the provisions of this Agreement, including the Prospectus, amendments and supplements to such Registration Statement, including
post-effective amendments, all exhibits and all materials incorporated by reference in such Registration Statement.

 

“Rule 144” means
Rule 144 promulgated under the Securities Act or any successor rule thereto or any complementary rule thereto (such as Rule 144A).

 

“Securities
Act”  has the meaning given thereto in the Recitals.

 

“Selling Expenses” means
all underwriting discounts, selling commissions and stock transfer taxes applicable to the sale of Registrable Securities, and
fees and disbursements of counsel for any holder of Registrable Securities.

 

“SPA”
has the meaning set forth in the Recitals.

 

2.           Demand
Registration.

 

(a)          The
Company shall use its best efforts to qualify and remain qualified to register securities under the Securities Act pursuant to
a Registration Statement on Form S-3 or any successor form thereto. At such time as the Company shall have qualified for the use
of a Registration Statement on Form S-3, the holder of Registrable Securities shall have the right to request an unlimited number
of registrations under the Securities Act of all or any portion of its Registrable Securities pursuant to a Registration Statement
on Form S-3 or any similar short-form Registration Statement
(each a “Demand Registration”). Each request for a Demand Registration shall specify the approximate
number of Registrable Securities requested to be registered. The Company shall cause a Registration Statement on Form S-3 (or any
successor form) to be filed within ten (10) days after the date on which a Demand Registration request is given and shall use its
reasonable best efforts to cause such Registration Statement to be declared effective by the Commission as soon as practicable
thereafter and remain effective until the date on which the Investor has disposed of all of the Common Shares it requested to be
registered in such Demand Registration.

 

    3 

     

    

 

(b)          The
Company may postpone for up to ninety (90) days the filing or effectiveness of a Registration Statement for a Demand Registration
if the Company's Board determines in its reasonable good faith judgment that such Demand Registration would (i) materially interfere
with a significant acquisition, corporate organization or other similar transaction involving the Company; (ii) require premature
disclosure of material information that the Company has a bona fide business purpose for preserving as confidential; or (iii) render
the Company unable to comply with requirements under the Securities Act or Exchange Act.

 

(c)          If
the holder of the Registrable Securities requesting a Demand Registration elects to distribute the Registrable Securities covered
by its request in an underwritten offering, it shall so advise the Company as a part of their request made pursuant to Section
2(a). The holder of the Registrable Securities requesting the Demand Registration shall select the investment banking firm
or firms to act as the managing underwriter or underwriters in connection with such offering; provided, that such selection
shall be subject to the consent of the Company, which consent shall not be unreasonably withheld or delayed.

 

(d)          The
Company shall not grant registration rights to any other holder of the Company’s securities for a period of twelve (12) months
from the date of this Agreement.

 

(e)          The
Company shall not include in any Demand Registration any securities which are not Registrable Securities without the prior written
consent of the Investor, which consent shall not be unreasonably withheld or delayed. If a Demand Registration involves an underwritten
offering and the managing underwriter of the requested Demand Registration advises the Company and Investor in writing that in
its reasonable and good faith opinion the number of Common Shares proposed to be included in the Demand Registration, including
all Registrable Securities and all other Common Shares proposed to be included in such underwritten offering, exceeds the number
of shares of Common Shares which can be sold in such underwritten offering and/or the number of shares of Common Shares proposed
to be included in such Demand Registration would adversely affect the price per share of the Common Shares proposed to be sold
in such underwritten offering, the Company shall include in such Demand Registration (i) first, the Common Shares that the Investor
proposes to sell, and (ii) second, the Common Shares proposed to be included therein by any other Persons (including Common Shares
to be sold for the account of the Company and/or other holders of Common Shares) allocated among such Persons in such manner as
they may agree.

 

(f)          Nothing
contained in this Agreement shall prevent the Company from filing a registration statement solely for the Company’s account
including without limitation, a registration statement relating to any employee benefit plan filed on Form S-8 or similar form
or, with respect to any corporate reorganization or other transaction under Rule 145 of the Securities Act, a registration
statement on Form S-4 or similar form, or any registration statement relating to the registration of securities issued to raise
financing for the Company.

 

    4 

     

    

 

3.           Lock-up
Agreement. Each holder of Registrable Securities agrees that in connection with any public offering of the Company's Common
Stock or other equity securities, and upon the request of the managing underwriter in such offering, such holder shall not, without
the prior written consent of such managing underwriter, during the thirty (30) days prior to the effective date of such registration
and ending on the date specified by such managing underwriter (such period not to exceed ninety (90) days in the case of any registration)
(a) offer, pledge, sell, contract to sell, grant any option or contract to purchase, purchase any option or contract to sell, hedge
the beneficial ownership of or otherwise dispose of, directly or indirectly, any Common Shares or any securities convertible into,
exercisable for or exchangeable for Common Shares (whether such shares or any such securities are then owned by the Holder or are
thereafter acquired), or (b) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the
economic consequences of ownership of such securities, whether any such transaction described in clause (a) or (b) above is to
be settled by delivery of Common Stock or such other securities, in cash or otherwise. The foregoing provisions of this Section
3 shall not apply to sales of Registrable Securities to be included in such offering pursuant to Section 2(a) and shall
be applicable to the holder of Registrable Securities only if all officers and directors of the Company and all stockholders owning
more than ten (10%) percent of the Company's outstanding Common Stock are subject to the same restrictions. Each holder of Registrable
Securities agrees to execute and deliver such other agreements as may be reasonably requested by the Company or the managing underwriter
which are consistent with the foregoing or which are necessary to give further effect thereto. Notwithstanding anything to the
contrary contained in this Section 3, each holder of Registrable Securities shall be released, pro rata, from any lock-up
agreement entered into pursuant to this Section 3 in the event and to the extent that the managing underwriter or the Company
permit any discretionary waiver or termination of the restrictions of any lock-up agreement pertaining to any officer, director
or holder of greater than ten (10%) percent of the outstanding Common Stock.

 

4.           Registration
Procedures. If and whenever the holders of Registrable Securities request that any Registrable Securities be registered pursuant
to the provisions of this Agreement, the Company shall use its reasonable best efforts to effect the registration and the sale
of such Registrable Securities in accordance with the intended method of disposition thereof, and pursuant thereto the Company
shall as soon as reasonably practicable:

 

(a)          subject
to Section 2(a) prepare and file with a Registration Statement with respect to such Registrable Securities and use its reasonable
best efforts to cause such Registration Statement to become effective;

 

(b)          prepare
and file with the Commission such amendments, post-effective amendments and supplements to such Registration Statement and the
Prospectus used in connection therewith as may be necessary to keep such Registration Statement effective until all of such Registrable
Securities have been disposed of and to comply with the provisions of the Securities Act with respect to the disposition of such
Registrable Securities in accordance with the intended methods of disposition set forth in such Registration Statement;

 

    5 

     

    

 

(c)          within
a reasonable time before filing such Registration Statement, Prospectus or amendments or supplements thereto, furnish to counsel
selected by the holder of such Registrable Securities copies of such documents proposed to be filed, which documents shall be subject
to the review, comment and approval of such counsel;

 

(d)          notify
the selling holder of Registrable Securities, promptly after the Company receives notice thereof, of the time when such Registration
Statement has been declared effective or a supplement to any Prospectus forming a part of such Registration Statement has been
filed;

 

(e)          furnish
to the selling holder of Registrable Securities such number of copies of the Prospectus included in such Registration Statement
(including each preliminary Prospectus) and any supplement thereto (in each case including all exhibits and documents incorporated
by reference therein) and such other documents as such selling holder of Registrable Securities may reasonably request in order
to facilitate the disposition of the Registrable Securities owned by such it; provided, that the Company shall have no such
obligation to deliver the Prospectus or Prospectuses that are available on the Commission’s EDGAR system;

 

(f)          use
its reasonable best efforts to register or qualify such Registrable Securities under such other securities or “blue sky”
laws of such jurisdictions as the selling holder reasonably requests and do any and all other acts and things which may be reasonably
necessary or advisable to enable such holders to consummate the disposition in such jurisdictions of the Registrable Securities
owned by such holder; provided, that the Company shall not be required to qualify generally to do business, subject itself
to general taxation or consent to general service of process in any jurisdiction where it would not otherwise be required to do
so but for this Section 4(f);

 

(g)          notify
the selling holder of such Registrable Securities, at any time when a Prospectus relating thereto is required to be delivered under
the Securities Act, of the happening of any event as a result of which the Prospectus included in such Registration Statement contains
an untrue statement of a material fact or omits any fact necessary to make the statements therein not misleading, and, at the request
of such holder, the Company shall prepare a supplement or amendment to such Prospectus so that, as thereafter delivered to the
purchasers of such Registrable Securities, such Prospectus shall not contain an untrue statement of a material fact or omit to
state any fact necessary to make the statements therein not misleading;

 

(h)          make
available for inspection by the selling holder of Registrable Securities, any underwriter participating in any disposition pursuant
to such Registration Statement and any attorney, accountant or other agent retained by such holder or underwriter (collectively,
the “Inspectors”), all financial and other records, pertinent corporate documents and properties of the Company
(collectively, the “Records”), and cause the Company's officers, directors and employees to supply all information
reasonably requested by any such Inspector in connection with such Registration Statement;

 

    6 

     

    

 

(i)          provide
a transfer agent and registrar (which may be the same entity) for all such Registrable Securities not later than the effective
date of such registration;

 

(j)          use
its reasonable best efforts to cause such Registrable Securities to be listed on each securities exchange on which the Common Stock
is then listed;

 

(k)          in
connection with an underwritten offering, enter into such customary agreements (including underwriting and lock-up agreements in
customary form) and take all such other customary actions as the holders of such Registrable Securities or the managing underwriter
of such offering reasonably request in order to expedite or facilitate the disposition of such Registrable Securities (including,
without limitation, making appropriate officers of the Company available to participate in “road show” and other customary
marketing activities (including one-on-one meetings with prospective purchasers of the Registrable Securities);

 

(l)          otherwise
use its reasonable best efforts to comply with all applicable rules and regulations of the Commission and make available to its
stockholders an earnings statement (in a form that satisfies the provisions of Section 11(a) of the Securities Act and Rule 158
thereunder) no later than thirty (30) days after the end of the 12-month period beginning with the first day of the Company's first
full fiscal quarter after the effective date of such Registration Statement, which earnings statement shall cover said 12-month
period, and which requirement will be deemed to be satisfied if the Company timely files complete and accurate information on Forms
10-Q, 10-K and 8-K under the Exchange Act and otherwise complies with Rule 158 under the Securities Act; and

 

(m)         furnish
to the selling holder of Registrable Securities and each underwriter, if any, with (i) a legal opinion of the Company's outside
counsel, dated the effective date of such Registration Statement (and, if such registration includes an underwritten public offering,
dated the date of the closing under the underwriting agreement), in form and substance as is customarily given in opinions of the
Company's counsel to underwriters in underwritten public offerings; and (ii) a “comfort” letter signed by the Company's
independent certified public accountants in form and substance as is customarily given in accountants' letters to underwriters
in underwritten public offerings;

 

(n)          without
limiting Section 4(f) above, use its reasonable best efforts to cause such Registrable Securities to be registered with
or approved by such other governmental agencies or authorities as may be necessary by virtue of the business and operations of
the Company to enable the holder of such Registrable Securities to consummate the disposition of such Registrable Securities in
accordance with its intended method of distribution thereof;

 

    7 

     

    

 

(o)          notify
the holder of Registrable Securities promptly of any request by the Commission for the amending or supplementing of such Registration
Statement or Prospectus or for additional information;

 

(p)          advise
the holder of Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of the issuance of any
stop order by the Commission suspending the effectiveness of such Registration Statement or the initiation or threatening of any
proceeding for such purpose and promptly use its reasonable best efforts to prevent the issuance of any stop order or to obtain
its withdrawal at the earliest possible moment if such stop order should be issued;

 

(q)          permit
any holder of Registrable Securities which holder, in its sole and exclusive judgment, might be deemed to be an underwriter or
a controlling person of the Company, to participate in the preparation of such Registration Statement and to require the insertion
therein of language, furnished to the Company in writing, which in the reasonable judgment of such holder and its counsel should
be included;

 

(r)          cooperate
with the selling holder of Registrable Securities to facilitate the timely preparation and delivery of certificates representing
the Registrable Securities to be sold pursuant to such Registration Statement or Rule 144, subject to compliance with the requirements
thereof and, if requested by the Company, the provision of an opinion of counsel reasonably acceptable to the Company as to such
compliance and related matters, free of any restrictive legends and representing such number of Common Shares and registered in
such names as Investor may reasonably request a reasonable period of time prior to sales of Registrable Securities pursuant to
such Registration Statement or Rule 144; provided , that the Company may satisfy its obligations hereunder without issuing physical
stock certificates through the use of The Depository Trust Company’s Direct Registration System (the “DTCDRS”);
and

 

(s)          otherwise
use its reasonable best efforts to take all other steps necessary to effect the registration of such Registrable Securities contemplated
hereby.

 

5.           Expenses.
All expenses (other than Selling Expenses) incurred by the Company in complying with its obligations pursuant to this Agreement
and in connection with the registration and disposition of Registrable Securities, including, without limitation, all registration
and filing fees, underwriting expenses (other than fees, commissions or discounts), expenses of any audits incident to or required
by any such registration, fees and expenses of complying with securities and “blue sky” laws, printing expenses and
fees and expenses of the Company’s counsel and accountants shall be borne by the Company. All Selling Expenses relating to
Registrable Securities registered pursuant to this Agreement shall be borne and paid by the holder of such Registrable Securities.

 

    8 

     

    

 

6.           Indemnification.

 

(a)          The
Company shall indemnify and hold harmless, to the fullest extent permitted by law, the holder of Registrable Securities, such holder's
officers, directors, managers, members, partners, stockholders and Affiliates, each underwriter, broker or any other Person acting
on behalf of such holder of Registrable Securities and each other Person, if any, who controls any of the foregoing Persons within
the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, against all losses, claims, actions, damages,
liabilities and expenses, joint or several, to which any of the foregoing Persons may become subject under the Securities Act or
otherwise, insofar as such losses, claims, actions, damages, liabilities or expenses arise out of or are based upon any untrue
or alleged untrue statement of a material fact contained in any Registration Statement, Prospectus, preliminary Prospectus, free
writing prospectus (as defined in Rule 405 promulgated under the Securities Act) or any amendment thereof or supplement thereto
or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein
not misleading, or any violation or alleged violation by the Company of the Securities Act or any other similar federal or state
securities laws or any rule or regulation promulgated thereunder applicable to the Company and relating to action or inaction required
of the Company in connection with any such registration, qualification or compliance; and shall reimburse such Persons for any
legal or other expenses reasonably incurred by any of them in connection with investigating or defending any such loss, claim,
action, damage or liability, except insofar as the same are caused by or contained in any information furnished in writing to the
Company by such holder expressly for use therein or by such holder's failure to deliver a copy of the Registration Statement, Prospectus,
free-writing prospectus (as defined in Rule 405 promulgated under the Securities Act) or any amendments or supplements thereto
(if the same was required by applicable law to be so delivered) after the Company has furnished such holder with a sufficient number
of copies of the same prior to any written confirmation of the sale of Registrable Securities.

 

(b)          In
connection with any registration in which a holder of Registrable Securities is participating, such holder shall furnish to the
Company in writing such information and affidavits as the Company reasonably requests for use in connection with any such Registration
Statement or Prospectus and, to the extent permitted by law, shall indemnify and hold harmless, the Company, each director of the
Company, each officer of the Company who shall sign such Registration Statement, each underwriter, broker or other Person acting
on behalf of the holders of Registrable Securities and each Person who controls any of the foregoing Persons within the meaning
of Section 15 of the Securities Act or Section 20 of the Exchange Act against any losses, claims, actions, damages, liabilities
or expenses resulting from any untrue or alleged untrue statement of material fact contained in the Registration Statement, Prospectus,
preliminary Prospectus, free writing prospectus (as defined in Rule 405 promulgated under the Securities Act) or any amendment
thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary
to make the statements therein not misleading, but only to the extent that such untrue statement or omission is contained in any
information or affidavit so furnished in writing by such holder; provided, that the obligation to indemnify shall be limited
to the net proceeds (after underwriting fees, commissions or discounts) actually received by such holder from the sale of Registrable
Securities pursuant to such Registration Statement.

 

    9 

     

    

 

(c)          Promptly
after receipt by an indemnified party of notice of the commencement of any action involving a claim referred to in this Section
6, such indemnified party shall, if a claim in respect thereof is made against an indemnifying party, give written notice to
the latter of the commencement of such action. The failure of any indemnified party to notify an indemnifying party of any such
action shall not (unless such failure shall have a material adverse effect on the indemnifying party) relieve the indemnifying
party from any liability in respect of such action that it may have to such indemnified party hereunder. In case any such action
is brought against an indemnified party, the indemnifying party shall be entitled to participate in and to assume the defense of
the claims in any such action that are subject or potentially subject to indemnification hereunder, jointly with any other indemnifying
party similarly notified to the extent that it may wish, with counsel reasonably satisfactory to such indemnified party, and after
written notice from the indemnifying party to such indemnified party of its election so to assume the defense thereof, the indemnifying
party shall not be responsible for any legal or other expenses subsequently incurred by the indemnified party in connection with
the defense thereof; provided, that if (i) any indemnified party shall have reasonably concluded that there may be one or
more legal or equitable defenses available to such indemnified party which are additional to or conflict with those available to
the indemnifying party, or that such claim or litigation involves or could have an effect upon matters beyond the scope of the
indemnity provided hereunder, or (ii) such action seeks an injunction or equitable relief against any indemnified party or involves
actual or alleged criminal activity, the indemnifying party shall not have the right to assume the defense of such action on behalf
of such indemnified party without such indemnified party's prior written consent (but, without such consent, shall have the right
to participate therein with counsel of its choice) and such indemnifying party shall reimburse such indemnified party and any Person
controlling such indemnified party for that portion of the fees and expenses of any counsel retained by the indemnified party which
is reasonably related to the matters covered by the indemnity provided hereunder. If the indemnifying party is not entitled to,
or elects not to, assume the defense of a claim, it shall not be obligated to pay the fees and expenses of more than one counsel
for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified
party a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to
such claim. In such instance, the conflicting indemnified parties shall have a right to retain one separate counsel, chosen by
the holder of the Registrable Securities included in the registration, at the expense of the indemnifying party.

 

    10 

     

    

 

(d)          If
the indemnification provided for hereunder is held by a court of competent jurisdiction to be unavailable to an indemnified party
with respect to any loss, claim, damage, liability or action referred to herein, then the indemnifying party, in lieu of indemnifying
such indemnified party hereunder, shall contribute to the amounts paid or payable by such indemnified party as a result of such
loss, claim, damage, liability or action in such proportion as is appropriate to reflect the relative fault of the indemnifying
party on the one hand and of the indemnified party on the other in connection with the statements or omissions which resulted in
such loss, claim, damage, liability or action as well as any other relevant equitable considerations; provided, that the
maximum amount of liability in respect of such contribution shall be limited, in the case of the holder of Registrable Securities,
to an amount equal to the net proceeds (after underwriting fees, commissions or discounts) actually received by such seller from
the sale of Registrable Securities effected pursuant to such registration. The relative fault of the indemnifying party and of
the indemnified party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of
a material fact or the omission or alleged omission to state a material fact relates to information supplied by the indemnifying
party or by the indemnified party and the parties' relative intent, knowledge, access to information and opportunity to correct
or prevent such statement or omission. The parties agree that it would not be just and equitable if contribution pursuant hereto
were determined by pro rata allocation or by any other method or allocation which does not take account of the equitable considerations
referred to herein. No Person guilty or liable of fraudulent misrepresentation shall be entitled to contribution from any Person.

 

7.           Participation
in Underwritten Registrations. No Person may participate in any registration hereunder which is underwritten unless such Person
(a) agrees to sell such Person's securities on the basis provided in any underwriting arrangements approved by the Person or Persons
entitled hereunder to approve such arrangements and (b) completes and executes all questionnaires, powers of attorney, indemnities,
underwriting agreements and other documents required under the terms of such underwriting arrangements.

 

8.           Rule
144 Compliance. With a view to making available to the holder of Registrable Securities the benefits of Rule 144 under the
Securities Act and any other rule or regulation of the Commission that may at any time permit a holder to sell securities of the
Company to the public without registration or pursuant to a registration on Form S-3 (or any successor form), the Company shall:

 

(a)          make
and keep public information available, as those terms are understood and defined in Rule 144 under the Securities Act, at all times
after the Registration Date;

 

(b)          use
reasonable best efforts to file with the Commission in a timely manner all reports and other documents required of the Company
under the Securities Act and the Exchange Act, at any time after the Company has become subject to such reporting requirements;
and

 

(c)          furnish
to the holder so long as the holder owns Registrable Securities, promptly upon request, a written statement by the Company as to
its compliance with the reporting requirements of Rule 144 under the Securities Act and of the Securities Act and the Exchange
Act, a copy of the most recent annual or quarterly report of the Company, and such other reports and documents so filed or furnished
by the Company as such holder may reasonably request in connection with the sale of Registrable Securities without registration.

 

    11 

     

    

 

9.           Preservation
of Rights. The Company shall not without the prior written consent of the Investor: (a)
grant any registration rights to third parties which are more favorable than or inconsistent with the rights granted hereunder,
or (b) enter into any agreement, take any action, or permit any change to occur, with respect to its securities that violates or
subordinates the rights expressly granted to the holders of Registrable Securities in this Agreement.

 

10.          Termination.
This Agreement shall terminate and be of no further force or effect when there shall no longer be any Registrable Securities outstanding;
provided, that the provisions of Section 5, Section 6, Section 11 and Sections 12 through 19 shall
survive any such termination.

 

11.          Notices.
All notices, requests, consents, claims, demands, waivers and other communications hereunder shall be in writing and shall be deemed
to have been given (a) when delivered by hand (with written confirmation of receipt); (b) when received by the addressee if sent
by a nationally recognized overnight courier (receipt requested); or (c) on the fifth day after the date mailed, by certified or
registered mail, return receipt requested, postage prepaid. Such communications must be sent to the respective parties at the addresses
indicated below (or at such other address for a party as shall be specified in a notice given in accordance with this Section
11).

 

	If to the Company:	 	
        Twinlab Consolidated Holdings, Inc.

        632 Broadway, Suite 201

        New York, NY 10012

        Attention: General Counsel 

         

	with a copy to (which shall not constitute notice to the Company):	 	Wilk Auslander LLP

1515 Broadway

New York, NY 10036

Attention: Joel I. Frank, Esq.
	
         

        If to the Registered Owner:
	 	
         

        Golisano Holdings LLC

        One Fisher Road

        Pittsford, NY 14534

        Attention: B. Thomas Golisano, Member

	
         

        with a copy to (which shall not constitute notice to the Registered
        Owner):
	 	
         

        Woods Oviatt Gilman, LLP

        Suite 700

        Two State Street

        Rochester, NY 14614

        Attention: Gordon E. Forth, Esq.

 

    12 

     

    

 

12.          Entire
Agreement. This Agreement, together with the SPA, and any related exhibits and schedules thereto, constitutes the sole and
entire agreement of the parties to this Agreement with respect to the subject matter contained herein, and supersedes all prior
and contemporaneous understandings and agreements, both written and oral, with respect to such subject matter. Notwithstanding
the foregoing, in the event of any conflict between the terms and provisions of this Agreement and those of the SPA, the terms
and conditions of this Agreement shall control.

 

13.          Successor
and Assigns. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective
successors and permitted assigns. The Company may assign this Agreement at any time in connection with a sale or acquisition of
the Company, whether by merger, consolidation, sale of all or substantially all of the Company’s assets, or similar transaction,
without the consent of the Investor; provided , that the successor or acquiring Person agrees in writing to assume all of the Company’s
rights and obligations under this Agreement.  Investor may assign its rights hereunder to any purchaser or transferee of Registrable
Securities; provided, that such purchaser or transferee shall, as a condition to the effectiveness of such assignment, be
required to execute a counterpart to this Agreement agreeing to be treated as a holder of Registrable Securities whereupon such
purchaser or transferee shall have the benefits of, and shall be subject to the restrictions contained in, this Agreement as if
such purchaser or transferee was originally included in the definition of an Investor herein and had originally been a party hereto.

 

14.          No
Third-Party Beneficiaries. This Agreement is for the sole benefit of the parties hereto and their respective successors and
permitted assigns and nothing herein, express or implied, is intended to or shall confer upon any other Person any legal or equitable
right, benefit or remedy of any nature whatsoever, under or by reason of this Agreement.

 

15.          Headings.
The headings in this Agreement are for reference only and shall not affect the interpretation of this Agreement.

 

16.          Amendment,
Modification and Waiver. The provisions of this Agreement may only be amended, modified, supplemented or waived with the prior
written consent of the Company and the holder of the Registrable Securities. No waiver by any party or parties shall operate or
be construed as a waiver in respect of any failure, breach or default not expressly identified by such written waiver, whether
of a similar or different character, and whether occurring before or after that waiver. Except as otherwise set forth in this Agreement,
no failure to exercise, or delay in exercising, any right, remedy, power or privilege arising from this Agreement shall operate
or be construed as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder
preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege.

 

17.          Severability.
If any term or provision of this Agreement is invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality
or unenforceability shall not affect any other term or provision of this Agreement or invalidate or render unenforceable such term
or provision in any other jurisdiction. Upon such determination that any term or other provision is invalid, illegal or unenforceable,
the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as
closely as possible in a mutually acceptable manner in order that the transactions contemplated hereby be consummated as originally
contemplated to the greatest extent possible.

 

    13 

     

    

 

18.          Remedies.
The holder of Registrable Securities, in addition to being entitled to exercise all rights granted by law, including recovery of
damages, shall be entitled to specific performance of its rights under this Agreement. The Company acknowledges that monetary damages
would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Agreement and the
Company hereby agrees to waive the defense in any action for specific performance that a remedy at law would be adequate.

 

19.          Governing
Law; Submission to Jurisdiction. This Agreement shall be governed by and construed in accordance with the internal laws of
the State of New York without giving effect to any choice or conflict of law provision or rule (whether of the State of New York
or any other jurisdiction). Any legal suit, action or proceeding arising out of or based upon this Agreement or the transactions
contemplated hereby may be instituted in the federal courts of the United States or the courts of the State of New York in each
case located in the State of New York, and each party irrevocably submits to the exclusive jurisdiction of such courts in any such
suit, action or proceeding. Service of process, summons, notice or other document by mail to such party's address set forth herein
shall be effective service of process for any suit, action or other proceeding brought in any such court. The parties irrevocably
and unconditionally waive any objection to the laying of venue of any suit, action or any proceeding in such courts and irrevocably
waive and agree not to plead or claim in any such court that any such suit, action or proceeding brought in any such court has
been brought in an inconvenient forum.

 

20.          Waiver
of Jury Trial. Each party acknowledges and agrees that any controversy which may arise under this Agreement is likely to involve
complicated and difficult issues and, therefore, each such party irrevocably and unconditionally waives any right it may have to
a trial by jury in respect of any legal action arising out of or relating to this Agreement or the transactions contemplated hereby.
Each party to this Agreement certifies and acknowledges that (a) no representative of any other party has represented, expressly
or otherwise, that such other party would not seek to enforce the foregoing waiver in the event of a legal action, (b) such party
has considered the implications of this waiver, (c) such party makes this waiver voluntarily, and (d) such party has been induced
to enter into this Agreement by, among other things, the mutual waivers and certifications in this Section 20.

 

21.          Counterparts.
This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed
to be one and the same agreement. A signed copy of this Agreement delivered by facsimile, e-mail or other means of electronic transmission
shall be deemed to have the same legal effect as delivery of an original signed copy of this Agreement.

 

[SIGNATURE PAGE FOLLOWS]

 

    14 

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Registration Rights Agreement as of the date first written above.

 

	 	TWINLAB CONSOLIDATED HOLDINGS, INC.
	 	 
	 	By:	/s/ Thomas A. Tolworthy
	 	Name: Thomas A. Tolworthy
	 	Title: President and Chief Executive Officer
	 	 
	 	GOLISANO HOLDINGS LLC
	 	 	 
	 	By:	/s/ B. Thomas Golisano
	 	Name: B. Thomas Golisano
	 	Title: Member

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00250-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00250-of-00352.parquet"}]]